Tag: Attralus Inc.


Innovation Developed by UT Health Sciences Research Program Passes Landmark Trial for Cardiac Amyloidosis

|
Portrait of Dr. Jon Wall sitting in a lab in front of shelves containing scientific instruments and materials

A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a progressive and frequently underdiagnosed disease caused by abnormal protein deposits in the heart. The tool is a novel imaging technology, a radioactive molecule that, when injected into a patient and… Read More